The Scale of What We Are Discussing
Egg donation is one of the fastest-growing areas of assisted reproduction globally. In 2021, ESHRE data indicated that donor egg cycles accounted for approximately 16% of all ART cycles performed in Europe — and that proportion has continued to rise, driven by increasing rates of deferred childbearing, greater awareness of age-
related fertility decline, and expanded access to international fertility treatment. In South Africa, egg donation operates within one of the most ethically considered regulatory frameworks on the continent — governed by the National Health Act and guided by principles that prohibit commercialisation while permitting reasonable
compensation for donors. Understanding this landscape matters for anyone supporting patients navigating egg donation. Globally, the regulatory environment is fragmented — varying dramatically between jurisdictions in ways that directly shape where patients travel, what protections donors receive, and what information donor-conceived children will eventually have access to.
The Compensation Question
In countries where egg donation is permitted and regulated, the question of donor compensation sits at a complex ethical intersection. Fully commercial egg donation — where donors are primarily motivated by
significant financial incentive — raises legitimate concerns about undue inducement, particularly among economically vulnerable populations. The risk of donors underreporting medical conditions, overstating their health history, or accepting risks they have not fully processed in the context of genuine financial pressure is real and documented. Yet the opposite extreme — requiring truly altruistic donation with no compensation whatsoever — creates its own access problems, restricting the donor pool and potentially making a route to parenthood unavailable to patients who need it. Most considered regulatory frameworks attempt to navigate this with ‘reasonable compensation’ models — covering genuine expenses and time without constituting payment for the eggs themselves. Whether this line is being maintained consistently across international markets is a question the industry should be asking more actively.
Anonymity, Identity, and What Donor-Conceived People Are Telling Us
The move away from anonymous egg donation in several major jurisdictions — including the UK, Australia, and parts of Europe — has been shaped significantly by the voices of donor-conceived adults and the research on their experiences. Studies on donor-conceived individuals consistently show that access to information about genetic origins is important to a significant proportion of that population — for reasons of identity, medical history, and basic human curiosity about where they come from. The research does not suggest that donor conception itself causes harm; it suggests that secrecy and denied access to information can. The shift toward identifiable donation and open-ID frameworks is an ethical development the industry should welcome, even where it creates short-term recruitment challenges. The interests of donor-conceived individuals are part of the ethical equation, not a secondary consideration.
Donor Welfare Is Not a Peripheral Concern
The welfare of egg donors — their physical safety, their informed consent, their psychological support, and their long-term follow-up — deserves far more structured attention than most regulatory frameworks currently require. Ovarian stimulation and egg retrieval are not without risk. OHSS, though significantly reduced in incidence through the adoption of GnRH agonist triggers and careful monitoring, has not been eliminated. Long-term follow-up of donors’ reproductive and general health outcomes remains inadequate at a population level.
Donors also deserve genuine informed consent — not a process designed to move them efficiently toward a signature, but one that ensures they have genuinely understood the medical procedure, the potential short and long-term implications, and their rights throughout the process.
A Conversation Worth Having Openly
Egg donation, done well, is an extraordinary act with the capacity to transform lives — for recipients, and often for donors who find genuine meaning in it. Done poorly, it can exploit vulnerability, compromise welfare, and fail the children who will eventually want to understand their own story. The fertility industry has a responsibility to hold both truths at once — to support access to donor conception while maintaining rigorous ethical standards that protect everyone involved.
I’d welcome perspectives from clinicians, counsellors, and donor programme coordinators: where do you see the most important ethical gaps in current practice? And what change would make the most meaningful difference?
